Long-circulating poly(ethylene glycol)-coated emulsions to target solid tumors

Drummond, 1999, Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors, Pharmacol. Rev., 51, 691 Brigger, 2002, Nanoparticles in cancer therapy and diagnosis, Adv. Drug Deliv. Rev., 54, 631, 10.1016/S0169-409X(02)00044-3 Le Garrec, 2004, Micelles in anticancer drug delivery, Am. J. Drug Deliv., 2, 15, 10.2165/00137696-200402010-00002 Takino, 1993, Controlled biodistribution of highly lipophilic drugs with various parenteral formulations, J. Drug Target., 1, 117, 10.3109/10611869308996067 Junping, 2003, Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol, Int. J. Pharm., 251, 13, 10.1016/S0378-5173(02)00580-X Maeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release, 65, 271, 10.1016/S0168-3659(99)00248-5 Greish, 2003, Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting, Clin. Pharmacokinet., 42, 1089, 10.2165/00003088-200342130-00002 Jain, 1997, Delivery of molecular and cellular medicine to solid tumors, Adv. Drug Deliv. Rev., 26, 71, 10.1016/S0169-409X(97)00027-6 Harris, 2001, Pegylation: a novel process for modifying pharmacokinetics, Clin. Pharmacokinet., 40, 539, 10.2165/00003088-200140070-00005 Torchilin, 1994, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity, Biochim. Biophys. Acta, 1195, 11, 10.1016/0005-2736(94)90003-5 Allen, 2002, Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol), Biosci. Rep., 22, 225, 10.1023/A:1020186505848 Blume, 1993, Molecular mechanism of the lipid vesicle longevity in vivo, Biochim. Biophys. Acta, 1146, 157, 10.1016/0005-2736(93)90351-Y Takino, 1994, Long circulating emulsion carrier systems for highly lipophilic drugs, Biol. Pharm. Bull., 17, 121, 10.1248/bpb.17.121 Allen, 1987, Large unilamellar liposomes with low uptake into the reticuloendothelial system, FEBS Lett., 223, 42, 10.1016/0014-5793(87)80506-9 Redgrave, 1992, Effects of sphingomyelin and phosphatidylcholine acyl chains on the clearance of triacylglycerol-rich lipoproteins from plasma. Studies with lipid emulsions in rats, Biochim. Biophys. Acta, 1126, 65, 10.1016/0005-2760(92)90218-K Webb, 1995, Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models, Br. J. Cancer, 72, 896, 10.1038/bjc.1995.430 Fenske, 1998, Ionophore-mediated uptake of ciprofloxacin and vincristine into large unilamellar vesicles exhibiting transmembrane ion gradients, Biochim. Biophys. Acta, 1414, 188, 10.1016/S0005-2736(98)00166-7 Webb, 1998, Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer, Cancer Chemother. Pharmacol., 42, 461, 10.1007/s002800050846 Semple, 2005, Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity, J. Pharm. Sci., 94, 1024, 10.1002/jps.20332 Boehlke, 2006, Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug, Expert Opin. Biol. Ther., 6, 409, 10.1517/14712598.6.4.409 Allen, 1981, A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles, Biochim. Biophys. Acta, 640, 385, 10.1016/0005-2736(81)90464-8 Barenholz, 1999, Sphingomyelin: biophysical aspects, Chem. Phys. Lipids, 102, 29, 10.1016/S0009-3084(99)00072-9 Allen, 1991, Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size, Biochim. Biophys. Acta, 1061, 56, 10.1016/0005-2736(91)90268-D Prankerd, 1990, The use of oil-in-water emulsions as a vehicle for parenteral drug administration, J. Parenter. Sci. Technol., 44, 139 Buszello, 2000, Emulsions as drug delivery systems, 191 Diehl, 2001, A good practice guide to the administration of substances and removal of blood, including routes and volumes, J. Appl. Toxicol., 21, 15, 10.1002/jat.727 Smaby, 1996, The interfacial elastic packing interactions of galactosylceramides, sphingomyelins, and phosphatidylcholines, Biophys. J., 70, 868, 10.1016/S0006-3495(96)79629-7 Li, 2000, Sphingomyelin interfacial behavior: the impact of changing acyl chain composition, Biophys. J., 78, 1921, 10.1016/S0006-3495(00)76740-3 Saito, 2000, Inhibition of lipoprotein lipase activity by sphingomyelin: role of membrane surface structure, Biochim. Biophys. Acta, 1486, 312, 10.1016/S1388-1981(00)00071-8 Chiu, 2003, Structure of sphingomyelin bilayers: a simulation study, Biophys. J., 85, 3624, 10.1016/S0006-3495(03)74780-8 Nyholm, 2003, Properties of palmitoyl phosphatidylcholine, sphingomyelin, and dihydrosphingomyelin bilayer membranes as reported by different fluorescent reporter molecules, Biophys. J., 84, 987, 10.1016/S0006-3495(03)74915-7 Floyd, 1999, Top ten considerations in the development of parenteral emulsions, PSTT, 2, 134 Liu, 1995, Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs, Pharm. Res., 12, 1060, 10.1023/A:1016274801930 Lundberg, 1996, Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation time, Int. J. Pharm., 134, 119, 10.1016/0378-5173(96)04456-0 Hoarau, 2004, Novel long-circulating lipid nanocapsules, Pharm. Res., 21, 1783, 10.1023/B:PHAM.0000045229.87844.21 Derksen, 1987, Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages, Biochim. Biophys. Acta, 931, 33, 10.1016/0167-4889(87)90047-4 Hobbs, 1998, Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment, Proc. Natl. Acad. Sci. USA, 95, 4607, 10.1073/pnas.95.8.4607 Gabizon, 1990, Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies, Cancer Res., 50, 6371 Khalid, 2006, Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors, Pharm. Res., 23, 752, 10.1007/s11095-006-9662-5 Mori, 1991, Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo, FEBS Lett., 284, 263, 10.1016/0014-5793(91)80699-4 Allen, 1991, Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo, Biochim. Biophys. Acta, 1066, 29, 10.1016/0005-2736(91)90246-5 Huang, 1992, Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice, Cancer Res., 52, 5135 Ishida, 1999, Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice, Int. J. Pharm., 190, 49, 10.1016/S0378-5173(99)00256-2 Kurihara, 1996, Enhanced tumor delivery and antitumor activity of palmitoyl rhizoxin using stable lipid emulsions in mice, Pharm. Res., 13, 305, 10.1023/A:1016063719541 Wang, 2002, Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG-lipid, J. Pharm. Sci., 91, 1128, 10.1002/jps.10104 Constantinides, 2000, Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel, Pharm. Res., 17, 175, 10.1023/A:1007565230130 Constantinides, 2004, Tocol emulsions for drug solubilization and parenteral delivery, Adv. Drug Deliv. Rev., 56, 1243, 10.1016/j.addr.2003.12.005 Fukushima, 2000, Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin, Adv. Drug Deliv. Rev., 45, 65, 10.1016/S0169-409X(00)00101-0 Constantinides, 2006, Advances in the use of tocols as drug delivery vehicles, Pharm. Res., 23, 243, 10.1007/s11095-005-9262-9